Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“All analyses were adjusted for eigenvectors 1–20 from principal component analyses to account for possible confounding by population substructure within each cohort (22,43).”
MethodFinding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
GCTA: a tool for genome-wide complex trait analysis
Yang, J., Lee, S. H., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.011 · Cited by 8,279 · cited 15×
“It was necessary to employ more stringent quality control that what is generally acceptable for GWASs because systematic differences between cases and controls could be picked up as genetic variance (3).”
BackgroundMethodInfluentialThe combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Common SNPs explain a large proportion of the heritability for human height
Yang, J., Benyamin, B., McEvoy, B. P., Gordon, S., Henders, A. K., Nyholt, D. R., Madden, P. A., Heath, A. C., Martin, N. G., Montgomery, G. W., et al. (2010) · Nature Genetics · doi:10.1038/ng.608 · Cited by 4,446 · cited 2×
“case population and to control for ascertainment, we used GCTA to transform the explained variance estimate from the observed scale (V(1)/Vp) to the underlying scale (V(1)/ Vp_L).”
Methodα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Self-citationMulticenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationMaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes
Li, Y., Willer, C. J., Ding, J., Scheet, P., & Abecasis, G. R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20533 · Cited by 1,843 · cited 5×
“A quality threshold of a minimum 0.30 squared correlation between proximal, experimental and imputed genotypes was applied, indicated by the R 2 metric from MACH (41,42).”
MethodInfluentialGenome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Self-citationIncidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Genomewide Association Studies and Assessment of the Risk of Disease
Manolio, T. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905980 · Cited by 1,512
Uncertainty in heterogeneity estimates in meta-analyses
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · BMJ · doi:10.1136/bmj.39343.408449.80 · Cited by 1,254
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · cited 1×
“This is a similar prevalence value to what is seen in other population-based studies of PD prevalence (4,8,17,18).”
ResultAre Rare Variants Responsible for Susceptibility to Complex Diseases?
Pritchard, J. K. (2001) · The American Journal of Human Genetics · doi:10.1086/321272 · Cited by 1,197
Wang, E.-S., Yao, H.-B., Chen, Y.-H., Wang, G., Gao, W.-W., Sun, Y.-R., Guo, J.-G., Hu, J.-W., Jiang, C.-C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,176
Uncovering the roles of rare variants in common disease through whole-genome sequencing
Cirulli, E. T., & Goldstein, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2779 · Cited by 1,136
Estimating Missing Heritability for Disease from Genome-wide Association Studies
Lee, S. H., Wray, N. R., Goddard, M. E., & Visscher, P. M. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.002 · Cited by 1,064 · cited 2×
“GRMs were calculated for each subset of data to determine the genetic relationship between pairs of individuals (3,22).”
MethodLi, Y., Willer, C., Sanna, S., & Abecasis, G. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164242 · Cited by 990
(2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 901 · cited 10×
“Additional detail regarding specific cohort-level quality control measures is described elsewhere (32,40).”
BackgroundMethodInfluentialSelf-citationGenome partitioning of genetic variation for complex traits using common SNPs
Yang, J., Manolio, T. A., Pasquale, L. R., Boerwinkle, E., Caporaso, N., Cunningham, J. M., de Andrade, M., Feenstra, B., Feingold, E., Hayes, M. G., et al. (2011) · Nature Genetics · doi:10.1038/ng.823 · Cited by 890
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696 · cited 11×
“It was necessary to employ more stringent quality control that what is generally acceptable for GWASs because systematic differences between cases and controls could be picked up as genetic variance (3).”
BackgroundInfluentialSelf-citationThe cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B.-M. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002548 · Cited by 529 · cited 8×
“(48); Nalls and colleagues (32) NMD3 rs34016896 3 34 016 896 Plagnol and colleagues (34) MCCC1/LAMP3 rs10513789, rs11711441 3 184 242 767–184 303 969 Lill et al.”
BackgroundInfluentialSelf-citationDo, C. B., Tung, J. Y., Dorfman, E., Kiefer, A. K., Drabant, E. M., Francke, U., Mountain, J. L., Goldman, S. M., Tanner, C. M., Langston, J. W., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002141 · Cited by 515 · cited 11×
“This has been previously shown using sparse regression techniques, which account for 6–7% of total variance in GWAS SNPs, further suggesting the majority of genetic variants that contribute to PD lay outside of GWAS-significant SNPs (15).”
BackgroundMethodInfluentialGenomewide association study for susceptibility genes contributing to familial Parkinson disease
Pankratz, N., Wilk, J. B., Latourelle, J. C., DeStefano, A. L., Halter, C., Pugh, E. W., Doheny, K. F., Gusella, J. F., Nichols, W. C., Foroud, T., et al. (2009) · Human Genetics · doi:10.1007/s00439-008-0582-9 · Cited by 443 · cited 1×
“(35) (MF, n 1⁄4 1733); a Finnish case–control cohort was also incorporated into this study based on the Vantaa 85+ Study (38) (FIN 1⁄4 883; cases from Oulu, n 1⁄4 387; controls from mitoPARK and Vantaa 85+, n 1⁄4 496).”
MethodFung, H.-C., Scholz, S., Matarin, M., Simón-Sánchez, J., Hernandez, D., Britton, A., Gibbs, J. R., Langefeld, C., Stiegert, M. L., Schymick, J., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70578-6 · Cited by 389
Self-citationA Two-Stage Meta-Analysis Identifies Several New Loci for Parkinson's Disease
International Parkinson's Disease Genomics Consortium (IPDGC), & Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002142 · Cited by 314
Piccini, P., Burn, D. J., Ceravolo, R., Maraganore, D., & Brooks, D. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<577::aid-ana5>3.0.co;2-o · Cited by 304 · cited 2×
“Furthermore, a longitudinal twin study examined both MZ and DZ pairs over an 8-year period and observed a significantly higher concordance rate among MZ pairs; over time, concordance in these individuals increased from 0 to 33% (20).”
BackgroundFamilial Aggregation of Parkinson's Disease in Iceland
Sveinbjörnsdóttir, S., Hicks, A. A., Jónsson, T., Pétursson, H., Guðmundsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., & Stefánsson, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432404 · Cited by 275 · cited 1×
“Using GCTA, we aim to identify a larger segment of additive genetic variance not typically associated with early- and late-onset PD via GWASs in central European and Scandinavian ancestry populations, thus generating the most comprehensive estimates to date of PD heritability (23).”
BackgroundChromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study
Laaksovirta, H., Peuralinna, T., Schymick, J. C., Scholz, S. W., Lai, S.-L., Myllykangas, L., Sulkava, R., Jansson, L., Hernandez, D. G., Gibbs, J. R., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70184-8 · Cited by 259 · cited 4×
“Additional US participant data were obtained via dbGaP, made available by the NINDS Human Genetics Resource Center and have been described by Pankratz et al. (35) (MF, n ¼ 1733); a Finnish case – control cohort was also incorporated into this study based on the Vantaa 85+ Study (38) (FIN ¼ 883; cases from Oulu, n ¼ 38…”
MethodInfluentialSelf-citationThe UK Parkinson's Disease Consortium and The Wellcome Trust Case Control Consortium 2, Spencer, C. C. A., Plagnol, V., Strange, A., Gardner, M., Paisan-Ruiz, C., Band, G., Barker, R. A., Bellenguez, C., Bhatia, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq469 · Cited by 219
Self-citationGenetics of Parkinsonʼs disease
Gasser, T. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000170951.08924.3d · Cited by 192
Self-citationPapassotiropoulos, A., Bagli, M., Jessen, F., Bayer, T. A., Maier, W., Rao, M. L., & Heun, R. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3 · Cited by 186
Genome-wide association study confirms extant PD risk loci among the Dutch
Simón-Sánchez, J., van Hilten, J. J., van de Warrenburg, B., Post, B., Berendse, H. W., Arepalli, S., Hernandez, D. G., de Bie, R. M. A., Velseboer, D., Scheffer, H., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.254 · Cited by 181
Self-citationSaad, M., Lesage, S., Saint-Pierre, A., Corvol, J.-C., Zelenika, D., Lambert, J.-C., Vidailhet, M., Mellick, G. D., Lohmann, E., Durif, F., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq497 · Cited by 162
Self-citationPankratz, N., & Foroud, T. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31815bf97c · Cited by 154
Alcalay, R. N., Caccappolo, E., Mejia-Santana, H., Tang, M. X., Rosado, L., Ross, B. M., Verbitsky, M., Kisselev, S., Louis, E. D., Comella, C., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.194 · Cited by 145 · cited 1×
“In addition, mutations known to cause monogenic forms of PD account for only a small proportion of disease (11).”
BackgroundWickremaratchi, M. M., Perera, D., O'Loghlen, C., Sastry, D., Morgan, E., Jones, A., Edwards, P., Robertson, N. P., Butler, C., Morris, H. R., et al. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.162222 · Cited by 118 · cited 1×
“This is a similar prevalence value to what is seen in other population-based studies of PD prevalence (4,8,17,18).”
ResultSelf-citationNo evidence for heritability of Parkinson disease in Swedish twins
Wirdefeldt, K., Gatz, M., Schalling, M., & Pedersen, N. L. (2004) · Neurology · doi:10.1212/01.wnl.0000129841.30587.9d · Cited by 111
Towards a complete resolution of the genetic architecture of disease
Singleton, A. B., Hardy, J., Traynor, B. J., & Houlden, H. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.07.004 · Cited by 86 · cited 1×
“In addition, rare variants are thought to harbor larger deleterious effects than more common variants (29,30).”
BackgroundSelf-citationFamilial Aggregation of Parkinson Disease: A Comparative Study of Early-Onset and Late-Onset Disease
Payami, H., Zareparsi, S., James, D., & Nutt, J. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.848 · Cited by 85 · cited 1×
“GWASs have identified risk variants at over two dozen loci influencing PD risk; however, these are thought to explain only a fraction of the variance in PD liability (8,10).”
BackgroundCopy Number Variation in Familial Parkinson Disease
Pankratz, N., Dumitriu, A., Hetrick, K. N., Sun, M., Latourelle, J. C., Wilk, J. B., Halter, C., Doheny, K. F., Gusella, J. F., Nichols, W. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020988 · Cited by 81
Nalls, M. A., Simon-Sanchez, J., Gibbs, J. R., Paisan-Ruiz, C., Bras, J. T., Tanaka, T., Matarin, M., Scholz, S., Weitz, C., Harris, T. B., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000415 · Cited by 80 · cited 1×
“In particular, increasing homozygosity has been associated with chronological age (39).”
BackgroundSelf-citationHamza, T. H., & Payami, H. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.13 · Cited by 76
Familial aggregation of Parkinson's disease: A meta‐analysis
Thacker, E. L., & Ascherio, A. (2008) · Movement Disorders · doi:10.1002/mds.22067 · Cited by 75 · cited 1×
“Monogenic familial forms of PD are often early-onset, and it has been suggested that early-onset PD has a greater familial/heritable component in its etiology than later onset manifestations of the disease (19).”
BackgroundThe Lorhandicap Study Group, Niedhammer, I., Bourgkard, È., & Chau, N. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9506-9 · Cited by 66
Li, L., Li, Y., Browning, S. R., Browning, B. L., Slater, A. J., Kong, X., Aponte, J. L., Mooser, V., Chissoe, S. L., Whittaker, J. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024945 · Cited by 60 · cited 1×
“005) require reference panels with at least 1200 subjects in order to impute, as it is necessary to observe multiple copies of an SNP in order to accurately constitute the haplotypes that will be used for imputation (31).”
BackgroundThe Prevalence of Parkinson’s Disease in an Area of North Tyneside in the North-East of England
Porter, B., Macfarlane, R., Unwin, N., & Walker, R. (2006) · Neuroepidemiology · doi:10.1159/000091657 · Cited by 58
From Genes to Proteins in Mendelian Parkinson's Disease: An Overview
Cetinkaya, C. P., Lesage, S., Brice, A., & Başak, A. N. (2009) · The Anatomical Record · doi:10.1002/ar.20968 · Cited by 15
Self-citation
Research works printed but not linked: 1
- 2011, 8, e1002548
Cited by
Nalls, M. A., Blauwendraat, C., Vallerga, C. L., Heilbron, K., Bandres-Ciga, S., Chang, D., Tan, M., Kia, D. A., Noyce, A. J., Xue, A., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30320-5 · Cited by 2,454
Self-citationAnalysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationA meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Chang, D., Nalls, M. A., Hallgrímsdóttir, I. B., Hunkapiller, J., van der Brug, M., Cai, F., International Parkinson's Disease Genomics Consortium, 23andMe Research Team, Kerchner, G. A., Ayalon, G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3955 · Cited by 1,112
Self-citationReevaluation of SNP heritability in complex human traits
the UCLEB Consortium, Speed, D., Cai, N., Johnson, M. R., Nejentsev, S., & Balding, D. J. (2017) · Nature Genetics · doi:10.1038/ng.3865 · Cited by 456
Metadata
- Authors
- Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., Schulte, C., Moskvina, V., Durr, A., Holmans, P., Kilarski, L. L., Guerreiro, R., Hernandez, D. G., Brice, A., Ylikotila, P., Stefansson, H., Majamaa, K., Morris, H. R., Williams, N., Gasser, T., Heutink, P., Wood, N. W., Hardy, J., Martinez, M., Singleton, A. B., Nalls, M. A., & for the International Parkinson's Disease Genomics Consortium (IPDGC) and The Wellcome Trust Case Control Consortium 2 (WTCCC2)
- Affiliations
- National Institutes of Health (US)
- Université Toulouse III - Paul Sabatier (FR)
- deCODE Genetics (Iceland) (IS)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- German Center for Neurodegenerative Diseases (DE)
- Cardiff University (GB)
- UCL Queen Square Institute of Neurology (GB)
- Centre National de la Recherche Scientifique (FR)
- University of Turku (FI)
- University of Oulu (FI)
- Corresponding author
- Nalls, M. A.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-13
- Volume
- 21
- Issue
- 22
- Pages
- 4996-5009
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3576713
- OpenAlex
- W2132869184
- Cited by
- 190
- References
- 51
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 8 · 2023: 5 · 2022: 18 · 2021: 11 · 2020: 13 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 21 · 2015: 18 · 2014: 18 · 2013: 9 · 2012: 2
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Research Portal (Queen's University Belfast) (publishedVersion, other-oa)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- CLOK (University of Central Lancashire) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Wellcome Trust (083948/Z/07/Z, 090532, 089698, WT089698/Z/09/Z)
- National Institute for Health and Care Research (NF-SI-0507-10376)
- Parkinson's UK (G0909, J-0901, G-1107, J‐0804)
- National Institutes of Health (1z01es101986-03, UL1TR000448, Z01-ES101986, Z01-AG000949)
- Medical Research Council (MC_G1000735, MC_PC_09003, MC_G0901330)
- National Institute on Aging (Z01AG000949)
- National Institute of Neurological Disorders and Stroke (P30NS057105, NS057105, R01NS041509, R01NS075321)
- National Institute of Environmental Health Sciences (Z01-ES 101986)
- National Center for Research Resources (RR-024992, UL1RR024992)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and phenotypic traits in livestock
- Keywords
- Parkinson's disease, missing heritability, GCTA, heritability, early-onset Parkinson's disease, late-onset Parkinson's disease, genetic susceptibility loci
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Parkinson Disease, Genetic Variation, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Multifactorial Inheritance, White People, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.